Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Helve

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Rheumatology|January 1, 1978
Characterization of the DNA-synthesizing cells in rheumatoid synovial tissueP Nykänen, T Helve, U Kankaanpää, et al.
Scandinavian Journal of Rheumatology|January 1, 1993
The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritisL Paimela, M Leirisalo-Repo, T Helve, et al.
The Journal of Rheumatology|April 1, 1985
Nuclear matrix antibodies in rheumatic diseasesP Kurki, I Virtanen, V P Lehto, et al.
Rheumatology International|January 1, 1982
Circulating DNA-antibodies in systemic lupus erythematosusT Helve, A M Teppo, P Kurki, et al.
Scandinavian Journal of Immunology|February 1, 1994
Increased expression of VLA-5 adhesion molecules on synovial fluid T lymphocytes in chronic polyarthritis: a consequence of T-cell activationT K Walle, T Helve, I Virtanen, et al.
Rheumatology International|January 1, 1983
DNA antibodies and complement in SLE patients. A follow-up studyT Helve, P Kurki, A M Teppo, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Effect of treatment on the outcome of very early rheumatoid arthritisR Peltomaa, L Paimela, T Helve, et al.
Rheumatology International|January 1, 1984
DNA antibodies with and without complement-binding abilityA M Teppo, P Kurki, T Helve, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective studyR Peltomaa, L Paimela, T Helve, et al.
The Journal of Rheumatology|April 1, 2000
Effect of age on 3 year outcome in early rheumatoid arthritisR Peltomaa, M Leirisalo-Repo, T Helve, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Rheumatology|January 1, 1978
Characterization of the DNA-synthesizing cells in rheumatoid synovial tissueP Nykänen, T Helve, U Kankaanpää, et al.
Scandinavian Journal of Rheumatology|January 1, 1993
The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritisL Paimela, M Leirisalo-Repo, T Helve, et al.
The Journal of Rheumatology|April 1, 1985
Nuclear matrix antibodies in rheumatic diseasesP Kurki, I Virtanen, V P Lehto, et al.
Rheumatology International|January 1, 1982
Circulating DNA-antibodies in systemic lupus erythematosusT Helve, A M Teppo, P Kurki, et al.
Scandinavian Journal of Immunology|February 1, 1994
Increased expression of VLA-5 adhesion molecules on synovial fluid T lymphocytes in chronic polyarthritis: a consequence of T-cell activationT K Walle, T Helve, I Virtanen, et al.
Rheumatology International|January 1, 1983
DNA antibodies and complement in SLE patients. A follow-up studyT Helve, P Kurki, A M Teppo, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Effect of treatment on the outcome of very early rheumatoid arthritisR Peltomaa, L Paimela, T Helve, et al.
Rheumatology International|January 1, 1984
DNA antibodies with and without complement-binding abilityA M Teppo, P Kurki, T Helve, et al.
Scandinavian Journal of Rheumatology|January 1, 1995
Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective studyR Peltomaa, L Paimela, T Helve, et al.
The Journal of Rheumatology|April 1, 2000
Effect of age on 3 year outcome in early rheumatoid arthritisR Peltomaa, M Leirisalo-Repo, T Helve, et al.
Pageof 5